254 related articles for article (PubMed ID: 22930487)
1. Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency.
Benson S; Neumann P; Unger N; Schedlowski M; Mann K; Elsenbruch S; Petersenn S
Eur J Endocrinol; 2012 Nov; 167(5):679-85. PubMed ID: 22930487
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid Replacement Affects Serum Adiponectin Levels and HDL-C in Patients With Secondary Adrenal Insufficiency.
Hayashi R; Tamada D; Murata M; Kitamura T; Mukai K; Maeda N; Otsuki M; Shimomura I
J Clin Endocrinol Metab; 2019 Dec; 104(12):5814-5822. PubMed ID: 31290981
[TBL] [Abstract][Full Text] [Related]
3. Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized, placebo-controlled trial.
Nenke MA; Haylock CL; Rankin W; Inder WJ; Gagliardi L; Eldridge C; Rolan P; Torpy DJ
Psychoneuroendocrinology; 2015 Jun; 56():157-67. PubMed ID: 25827960
[TBL] [Abstract][Full Text] [Related]
4. Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR.
Murray RD; Ekman B; Uddin S; Marelli C; Quinkler M; Zelissen PM;
Clin Endocrinol (Oxf); 2017 Mar; 86(3):340-346. PubMed ID: 27801983
[TBL] [Abstract][Full Text] [Related]
5. Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial.
Werumeus Buning J; Konopka KH; Brummelman P; Koerts J; Dullaart RPF; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BHR; van Beek AP
PLoS One; 2017; 12(7):e0180326. PubMed ID: 28686664
[TBL] [Abstract][Full Text] [Related]
6. An observational study on adrenal insufficiency in a French tertiary centre: Real life versus theory.
Castinetti F; Sahnoun M; Albarel F; Morange I; Philippon M; Conte-Devolx B; Brue T
Ann Endocrinol (Paris); 2015 Feb; 76(1):1-8. PubMed ID: 25617904
[TBL] [Abstract][Full Text] [Related]
7. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
Isidori AM; Venneri MA; Graziadio C; Simeoli C; Fiore D; Hasenmajer V; Sbardella E; Gianfrilli D; Pozza C; Pasqualetti P; Morrone S; Santoni A; Naro F; Colao A; Pivonello R; Lenzi A
Lancet Diabetes Endocrinol; 2018 Mar; 6(3):173-185. PubMed ID: 29229498
[TBL] [Abstract][Full Text] [Related]
8. The effects of two different doses of hydrocortisone on cognition in patients with secondary adrenal insufficiency--results from a randomized controlled trial.
Werumeus Buning J; Brummelman P; Koerts J; Dullaart RP; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BH; van Beek AP
Psychoneuroendocrinology; 2015 May; 55():36-47. PubMed ID: 25705800
[TBL] [Abstract][Full Text] [Related]
9. Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens.
Bleicken B; Hahner S; Loeffler M; Ventz M; Allolio B; Quinkler M
Eur J Endocrinol; 2008 Dec; 159(6):811-7. PubMed ID: 18819943
[TBL] [Abstract][Full Text] [Related]
10. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial.
Gagliardi L; Nenke MA; Thynne TR; von der Borch J; Rankin WA; Henley DE; Sorbello J; Inder WJ; Torpy DJ
J Clin Endocrinol Metab; 2014 Nov; 99(11):4149-57. PubMed ID: 25127090
[TBL] [Abstract][Full Text] [Related]
11. Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy.
Noppe G; van Rossum EF; Vliegenthart J; Koper JW; van den Akker EL
Clin Endocrinol (Oxf); 2014 Dec; 81(6):820-5. PubMed ID: 25039686
[TBL] [Abstract][Full Text] [Related]
12. Self-perceived health status of patients with adrenal insufficiency receiving glucocorticoid replacement therapy - French data from a worldwide patient survey.
Touraine P; Chenuc G; Colin C
Ann Endocrinol (Paris); 2015 Feb; 76(1):9-12. PubMed ID: 25573224
[TBL] [Abstract][Full Text] [Related]
13. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency.
Bleicken B; Hahner S; Loeffler M; Ventz M; Decker O; Allolio B; Quinkler M
Clin Endocrinol (Oxf); 2010 Mar; 72(3):297-304. PubMed ID: 19508599
[TBL] [Abstract][Full Text] [Related]
14. Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial.
Binder G; Weber S; Ehrismann M; Zaiser N; Meisner C; Ranke MB; Maier L; Wudy SA; Hartmann MF; Heinrich U; Bettendorf M; Doerr HG; Pfaeffle RW; Keller E;
J Clin Endocrinol Metab; 2009 Apr; 94(4):1182-90. PubMed ID: 19126625
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency.
Ekman B; Bachrach-Lindström M; Lindström T; Wahlberg J; Blomgren J; Arnqvist HJ
Clin Endocrinol (Oxf); 2012 Jul; 77(1):18-25. PubMed ID: 22288685
[TBL] [Abstract][Full Text] [Related]
16. Modified-release prednisone decreases complaints and fatigue compared to standard prednisolone in patients with adrenal insufficiency.
Langenheim J; Ventz M; Hinz A; Quinkler M
Horm Metab Res; 2013 Feb; 45(2):96-101. PubMed ID: 22752958
[TBL] [Abstract][Full Text] [Related]
17. Management of steroid replacement in adrenal insufficiency.
Koetz K; Kienitz T; Quinkler M
Minerva Endocrinol; 2010 Jun; 35(2):61-72. PubMed ID: 20595936
[TBL] [Abstract][Full Text] [Related]
18. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
Oksnes M; Björnsdottir S; Isaksson M; Methlie P; Carlsen S; Nilsen RM; Broman JE; Triebner K; Kämpe O; Hulting AL; Bensing S; Husebye ES; Løvås K
J Clin Endocrinol Metab; 2014 May; 99(5):1665-74. PubMed ID: 24517155
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of two replacement regimens in primary adrenal insufficiency patients. effect on clinical symptoms, health-related quality of life and biochemical parameters.
Alonso N; Granada ML; Lucas A; Salinas I; Reverter J; Oriol A; Sanmarti A
J Endocrinol Invest; 2004 May; 27(5):449-54. PubMed ID: 15279078
[TBL] [Abstract][Full Text] [Related]
20. Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial.
van Thiel SW; Romijn JA; Pereira AM; Biermasz NR; Roelfsema F; van Hemert A; Ballieux B; Smit JW
J Clin Endocrinol Metab; 2005 Jun; 90(6):3295-303. PubMed ID: 15797966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
